Asia Pacific ePharmacy Market By Drug Type (Over-the-Counter Products and Prescription Medicines), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific ePharmacy Market
Market Report Description
The Asia Pacific ePharmacy Market would witness market growth of 17.8% CAGR during the forecast period (2021-2027).
The priorities of health systems have changed over the time since the outset of the COVID-19 pandemic. In addition, the pandemic compelled emerging nations to increase their focus on the priorities of infrastructure in non-rural centers. The pandemic emerged as a major challenge for various nations. Additionally, nations like India are focusing on taking strict actions to prevent the effects of COVID-19 and make it an opportunity to improve their healthcare infrastructure. Moreover, various government initiatives are aiming to improve and advance the healthcare system, hence, creating new growth opportunities for ePharmacy market.
The ePharmacy market in the Asia-Pacific would exhibit enormous growth in the forthcoming years. Nations like China and India are the major contributors for the ePharmacy market in the region. In addition, the Chinese government has been more involved in regulating the ePharmacy market.
Additionally, the ePharmacy market is at a developing stage in India as the number of customers is inclining towards purchasing medicines and health products through digital means. Also, ePharmacies are gradually gaining attention among customers as well as government. Moreover, around 250 ePharmacies have been set up in the nation in the past few years. Further, the demand for OTC medicines has increased in ePharmacy. Thus, these factors are anticipated to boost the growth of the regional market.
The China market dominated the Asia Pacific Over-the-Counter Products Market by Country in 2020, thereby, achieving a market value of $7,956.3 Million by 2027. The Japan market is exhibiting a CAGR of 18.3% during (2021 - 2027). Additionally, The India market is anticipated to witness a CAGR of 18.3% during (2021 - 2027).
Based on Drug Type, the market is segmented into Over-the-Counter Products and Prescription Medicines. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include The Kroger Co., Walgreen Co., Giant Eagle, Inc., Walmart, Inc., Express Scripts Holding Company (Cigna), CVS Health (CVS Pharmacy, Inc.), Optum Rx, Inc. (United Health Group), Rowlands Pharmacy (the PHOENIX group), DocMorris (Zur Rose Group AG), and Amazon Pharmacy (Amazon.com).
Scope of the Study
Market Segments Covered in the Report:
By Drug Type
- Over-the-Counter Products
- Prescription Medicines
- South Korea
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- The Kroger Co.
- Walgreen Co.
- Giant Eagle, Inc.
- Walmart, Inc.
- Express Scripts Holding Company (Cigna)
- CVS Health (CVS Pharmacy, Inc.)
- Optum Rx, Inc. (United Health Group)
- Rowlands Pharmacy (the PHOENIX group)
- DocMorris (Zur Rose Group AG)
- Amazon Pharmacy (Amazon.com)
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free